| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 96 | 2024 | 2373 | 12.380 |
Why?
|
| Radiotherapy, Intensity-Modulated | 60 | 2024 | 2107 | 8.930 |
Why?
|
| Image Processing, Computer-Assisted | 40 | 2023 | 1651 | 7.020 |
Why?
|
| Tomography, X-Ray Computed | 78 | 2024 | 7573 | 6.590 |
Why?
|
| Radiotherapy, Conformal | 17 | 2023 | 902 | 4.060 |
Why?
|
| Radiotherapy Dosage | 66 | 2024 | 3847 | 4.060 |
Why?
|
| Head and Neck Neoplasms | 36 | 2023 | 3978 | 3.970 |
Why?
|
| Organs at Risk | 27 | 2024 | 516 | 3.690 |
Why?
|
| Radiotherapy, Image-Guided | 15 | 2019 | 306 | 3.500 |
Why?
|
| Phantoms, Imaging | 33 | 2023 | 1275 | 3.320 |
Why?
|
| Particle Accelerators | 11 | 2021 | 355 | 3.170 |
Why?
|
| Uterine Cervical Neoplasms | 12 | 2024 | 1833 | 2.880 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 31 | 2023 | 5339 | 2.660 |
Why?
|
| Algorithms | 38 | 2023 | 3891 | 2.390 |
Why?
|
| Esophagitis | 5 | 2017 | 202 | 2.380 |
Why?
|
| Radiometry | 22 | 2022 | 983 | 2.370 |
Why?
|
| Patient Positioning | 5 | 2019 | 195 | 2.340 |
Why?
|
| Esophagus | 8 | 2023 | 554 | 2.220 |
Why?
|
| Automation | 12 | 2023 | 150 | 2.050 |
Why?
|
| Lung Neoplasms | 36 | 2023 | 11573 | 2.020 |
Why?
|
| Radiation Injuries | 12 | 2020 | 1412 | 1.990 |
Why?
|
| Cone-Beam Computed Tomography | 6 | 2018 | 203 | 1.810 |
Why?
|
| Immobilization | 5 | 2017 | 93 | 1.630 |
Why?
|
| Motion | 9 | 2018 | 194 | 1.610 |
Why?
|
| Software | 14 | 2023 | 1325 | 1.600 |
Why?
|
| Four-Dimensional Computed Tomography | 11 | 2023 | 226 | 1.570 |
Why?
|
| Healthcare Failure Mode and Effect Analysis | 2 | 2022 | 8 | 1.540 |
Why?
|
| Positron-Emission Tomography | 11 | 2023 | 2184 | 1.510 |
Why?
|
| Radiotherapy Setup Errors | 4 | 2019 | 80 | 1.460 |
Why?
|
| Artifacts | 9 | 2021 | 532 | 1.460 |
Why?
|
| Humans | 185 | 2024 | 262224 | 1.400 |
Why?
|
| Radiation Dosage | 16 | 2020 | 1016 | 1.390 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 7 | 2016 | 362 | 1.380 |
Why?
|
| Lung | 10 | 2020 | 3157 | 1.330 |
Why?
|
| Neck | 5 | 2023 | 382 | 1.320 |
Why?
|
| Thorax | 3 | 2018 | 213 | 1.310 |
Why?
|
| Reproducibility of Results | 36 | 2023 | 6036 | 1.280 |
Why?
|
| Cerebellar Neoplasms | 2 | 2023 | 434 | 1.270 |
Why?
|
| Cooperative Behavior | 2 | 2024 | 314 | 1.270 |
Why?
|
| Medulloblastoma | 2 | 2023 | 541 | 1.220 |
Why?
|
| Monte Carlo Method | 9 | 2020 | 672 | 1.170 |
Why?
|
| Radiation Oncology | 6 | 2023 | 529 | 1.160 |
Why?
|
| Respiration | 9 | 2019 | 447 | 1.070 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2019 | 1238 | 1.060 |
Why?
|
| Artificial Intelligence | 10 | 2024 | 389 | 1.040 |
Why?
|
| Mastectomy | 3 | 2024 | 1538 | 1.030 |
Why?
|
| Oropharyngeal Neoplasms | 5 | 2018 | 1108 | 1.020 |
Why?
|
| Models, Biological | 8 | 2018 | 3250 | 0.990 |
Why?
|
| International Cooperation | 2 | 2024 | 323 | 0.970 |
Why?
|
| Endoscopy | 2 | 2017 | 480 | 0.940 |
Why?
|
| Quality Assurance, Health Care | 7 | 2019 | 590 | 0.900 |
Why?
|
| Retrospective Studies | 39 | 2024 | 38010 | 0.860 |
Why?
|
| Thoracic Neoplasms | 3 | 2019 | 337 | 0.850 |
Why?
|
| Radiography, Thoracic | 4 | 2019 | 460 | 0.850 |
Why?
|
| Radiotherapy, Computer-Assisted | 3 | 2019 | 127 | 0.830 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 592 | 0.810 |
Why?
|
| Tumor Burden | 9 | 2019 | 1992 | 0.800 |
Why?
|
| Prostatic Neoplasms | 13 | 2023 | 5777 | 0.790 |
Why?
|
| Craniospinal Irradiation | 1 | 2023 | 128 | 0.780 |
Why?
|
| Quality Control | 3 | 2019 | 459 | 0.750 |
Why?
|
| Computer Simulation | 16 | 2024 | 1532 | 0.740 |
Why?
|
| Head | 5 | 2021 | 248 | 0.730 |
Why?
|
| Models, Theoretical | 3 | 2019 | 786 | 0.720 |
Why?
|
| Neoplasms | 13 | 2023 | 15204 | 0.720 |
Why?
|
| Radiotherapy | 4 | 2018 | 1826 | 0.710 |
Why?
|
| Radiopharmaceuticals | 6 | 2019 | 1311 | 0.710 |
Why?
|
| Heart | 7 | 2023 | 1225 | 0.680 |
Why?
|
| Proton Therapy | 7 | 2023 | 1577 | 0.680 |
Why?
|
| Prostate | 5 | 2023 | 1090 | 0.680 |
Why?
|
| Tomography, Spiral Computed | 2 | 2013 | 133 | 0.660 |
Why?
|
| Radiographic Image Enhancement | 4 | 2015 | 403 | 0.650 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2018 | 82 | 0.650 |
Why?
|
| Movement | 8 | 2019 | 557 | 0.640 |
Why?
|
| Electricity | 1 | 2018 | 17 | 0.630 |
Why?
|
| Biomarkers | 4 | 2021 | 5049 | 0.630 |
Why?
|
| Tomography Scanners, X-Ray Computed | 5 | 2019 | 88 | 0.620 |
Why?
|
| Thoracic Wall | 1 | 2020 | 184 | 0.610 |
Why?
|
| Rectal Neoplasms | 2 | 2024 | 1203 | 0.610 |
Why?
|
| Developing Countries | 1 | 2019 | 315 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2023 | 7727 | 0.570 |
Why?
|
| Female | 51 | 2024 | 142251 | 0.570 |
Why?
|
| Sensitivity and Specificity | 16 | 2016 | 4977 | 0.570 |
Why?
|
| Multimodal Imaging | 2 | 2023 | 550 | 0.560 |
Why?
|
| Internet | 4 | 2023 | 712 | 0.540 |
Why?
|
| Posture | 2 | 2014 | 215 | 0.530 |
Why?
|
| Magnetic Fields | 1 | 2015 | 31 | 0.530 |
Why?
|
| Breast Neoplasms | 5 | 2024 | 15710 | 0.520 |
Why?
|
| Organ Sparing Treatments | 2 | 2017 | 277 | 0.520 |
Why?
|
| Observer Variation | 9 | 2020 | 672 | 0.520 |
Why?
|
| Radiation Tolerance | 3 | 2017 | 629 | 0.520 |
Why?
|
| Rectum | 7 | 2024 | 468 | 0.500 |
Why?
|
| Calibration | 5 | 2018 | 337 | 0.490 |
Why?
|
| Feasibility Studies | 8 | 2023 | 2300 | 0.470 |
Why?
|
| Computed Tomography Angiography | 1 | 2015 | 234 | 0.470 |
Why?
|
| Male | 49 | 2024 | 123279 | 0.460 |
Why?
|
| Lymph Nodes | 3 | 2022 | 2969 | 0.460 |
Why?
|
| Skin | 2 | 2010 | 1260 | 0.450 |
Why?
|
| Aged | 33 | 2021 | 70323 | 0.440 |
Why?
|
| Uncertainty | 5 | 2018 | 321 | 0.420 |
Why?
|
| Contrast Media | 2 | 2015 | 1475 | 0.410 |
Why?
|
| Breast | 2 | 2018 | 1350 | 0.410 |
Why?
|
| Aged, 80 and over | 19 | 2021 | 29997 | 0.400 |
Why?
|
| Middle Aged | 33 | 2021 | 86446 | 0.390 |
Why?
|
| Skin Physiological Phenomena | 2 | 2008 | 42 | 0.390 |
Why?
|
| Subtraction Technique | 3 | 2015 | 142 | 0.380 |
Why?
|
| Benchmarking | 3 | 2021 | 272 | 0.370 |
Why?
|
| Workflow | 4 | 2021 | 276 | 0.370 |
Why?
|
| Protons | 1 | 2013 | 473 | 0.360 |
Why?
|
| Health Physics | 2 | 2020 | 63 | 0.350 |
Why?
|
| Carbon | 1 | 2010 | 150 | 0.340 |
Why?
|
| Dental Restoration, Permanent | 1 | 2009 | 5 | 0.340 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 121 | 0.340 |
Why?
|
| Mesothelioma | 3 | 2009 | 544 | 0.340 |
Why?
|
| Adult | 22 | 2023 | 78088 | 0.330 |
Why?
|
| Respiratory Mechanics | 3 | 2014 | 173 | 0.330 |
Why?
|
| Photons | 4 | 2021 | 507 | 0.320 |
Why?
|
| Pelvis | 2 | 2022 | 366 | 0.320 |
Why?
|
| Medical Errors | 1 | 2010 | 220 | 0.320 |
Why?
|
| Parotid Gland | 3 | 2023 | 111 | 0.320 |
Why?
|
| Prognosis | 11 | 2019 | 21747 | 0.310 |
Why?
|
| Respiratory-Gated Imaging Techniques | 3 | 2019 | 51 | 0.310 |
Why?
|
| ROC Curve | 4 | 2020 | 1180 | 0.310 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2017 | 927 | 0.300 |
Why?
|
| Optically Stimulated Luminescence Dosimetry | 2 | 2018 | 16 | 0.300 |
Why?
|
| Radiosurgery | 3 | 2019 | 1332 | 0.290 |
Why?
|
| Neoplasm Staging | 8 | 2019 | 13672 | 0.280 |
Why?
|
| Intra-Abdominal Fat | 2 | 2017 | 95 | 0.270 |
Why?
|
| Linear Models | 4 | 2021 | 1090 | 0.260 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2023 | 845 | 0.260 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 329 | 0.260 |
Why?
|
| Seminal Vesicles | 1 | 2005 | 152 | 0.250 |
Why?
|
| Brain | 5 | 2022 | 4113 | 0.250 |
Why?
|
| Pattern Recognition, Automated | 2 | 2015 | 126 | 0.250 |
Why?
|
| Brain Stem | 2 | 2023 | 175 | 0.240 |
Why?
|
| Cancer Survivors | 2 | 2021 | 650 | 0.240 |
Why?
|
| Spine | 2 | 2022 | 294 | 0.230 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2006 | 285 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2018 | 5436 | 0.220 |
Why?
|
| Dose-Response Relationship, Radiation | 5 | 2017 | 726 | 0.220 |
Why?
|
| Mice | 7 | 2018 | 34442 | 0.220 |
Why?
|
| Knowledge Bases | 1 | 2022 | 42 | 0.210 |
Why?
|
| Induction Chemotherapy | 2 | 2016 | 666 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 544 | 0.210 |
Why?
|
| Mechanical Phenomena | 2 | 2019 | 30 | 0.200 |
Why?
|
| Radiation Pneumonitis | 2 | 2018 | 301 | 0.200 |
Why?
|
| Patient Care Planning | 2 | 2022 | 297 | 0.200 |
Why?
|
| Cloud Computing | 1 | 2021 | 16 | 0.200 |
Why?
|
| Chemoradiotherapy | 4 | 2023 | 1947 | 0.190 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2023 | 325 | 0.190 |
Why?
|
| Nanotechnology | 2 | 2018 | 137 | 0.190 |
Why?
|
| Peer Review | 1 | 2021 | 80 | 0.190 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 5008 | 0.180 |
Why?
|
| Pharynx | 1 | 2020 | 153 | 0.180 |
Why?
|
| Prospective Studies | 6 | 2023 | 12914 | 0.180 |
Why?
|
| Models, Statistical | 4 | 2018 | 1177 | 0.180 |
Why?
|
| Brachytherapy | 2 | 2018 | 978 | 0.170 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 118 | 0.170 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 248 | 0.170 |
Why?
|
| Anus Neoplasms | 1 | 2023 | 412 | 0.170 |
Why?
|
| Breath Holding | 1 | 2019 | 44 | 0.170 |
Why?
|
| Electromagnetic Fields | 1 | 2018 | 50 | 0.170 |
Why?
|
| Poverty | 2 | 2022 | 471 | 0.170 |
Why?
|
| Computational Biology | 2 | 2023 | 1271 | 0.160 |
Why?
|
| Evaluation Studies as Topic | 1 | 2019 | 418 | 0.160 |
Why?
|
| Tongue Neoplasms | 2 | 2014 | 246 | 0.160 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 587 | 0.160 |
Why?
|
| Water | 2 | 2019 | 364 | 0.150 |
Why?
|
| Area Under Curve | 2 | 2019 | 701 | 0.150 |
Why?
|
| Clusterin | 1 | 2017 | 28 | 0.150 |
Why?
|
| Analysis of Variance | 2 | 2017 | 2311 | 0.150 |
Why?
|
| Statistics, Nonparametric | 2 | 2017 | 980 | 0.150 |
Why?
|
| Obesity, Abdominal | 1 | 2017 | 43 | 0.150 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 117 | 0.150 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 296 | 0.150 |
Why?
|
| Relative Biological Effectiveness | 2 | 2008 | 219 | 0.150 |
Why?
|
| Time Factors | 4 | 2020 | 12968 | 0.150 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 92 | 0.140 |
Why?
|
| Rubber | 1 | 2015 | 6 | 0.140 |
Why?
|
| Plant Structures | 1 | 2015 | 8 | 0.140 |
Why?
|
| Radiography | 3 | 2013 | 1912 | 0.140 |
Why?
|
| Equipment Design | 4 | 2018 | 1207 | 0.130 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 2 | 2015 | 260 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 384 | 0.130 |
Why?
|
| Cranial Irradiation | 1 | 2017 | 316 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2021 | 737 | 0.130 |
Why?
|
| Mediastinal Neoplasms | 1 | 2019 | 423 | 0.130 |
Why?
|
| Young Adult | 4 | 2023 | 21474 | 0.130 |
Why?
|
| Preoperative Period | 1 | 2016 | 344 | 0.130 |
Why?
|
| Radiation Equipment and Supplies | 1 | 2014 | 4 | 0.120 |
Why?
|
| Animals | 8 | 2018 | 59540 | 0.120 |
Why?
|
| Polyethylene | 1 | 2014 | 20 | 0.120 |
Why?
|
| Child | 4 | 2023 | 29137 | 0.120 |
Why?
|
| Exhalation | 1 | 2014 | 60 | 0.120 |
Why?
|
| Models, Organizational | 1 | 2015 | 75 | 0.120 |
Why?
|
| Karnofsky Performance Status | 1 | 2014 | 175 | 0.120 |
Why?
|
| Urinary Bladder | 3 | 2023 | 576 | 0.120 |
Why?
|
| Lung Volume Measurements | 1 | 2014 | 88 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 1329 | 0.120 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 1162 | 0.120 |
Why?
|
| Rotation | 1 | 2014 | 111 | 0.120 |
Why?
|
| Time | 1 | 2014 | 179 | 0.120 |
Why?
|
| Software Design | 1 | 2013 | 40 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 691 | 0.120 |
Why?
|
| Spinal Neoplasms | 1 | 2019 | 632 | 0.120 |
Why?
|
| Printing, Three-Dimensional | 1 | 2015 | 129 | 0.120 |
Why?
|
| Probability | 1 | 2015 | 868 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2015 | 306 | 0.120 |
Why?
|
| Tonsillar Neoplasms | 1 | 2014 | 80 | 0.120 |
Why?
|
| Thyroid Neoplasms | 2 | 2015 | 1867 | 0.120 |
Why?
|
| Machine Learning | 3 | 2023 | 320 | 0.120 |
Why?
|
| Video Recording | 1 | 2015 | 266 | 0.120 |
Why?
|
| Supine Position | 1 | 2013 | 46 | 0.110 |
Why?
|
| Reference Values | 1 | 2015 | 1098 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 14905 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 3752 | 0.110 |
Why?
|
| Swine | 1 | 2017 | 1552 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 948 | 0.110 |
Why?
|
| Carbon Isotopes | 1 | 2014 | 332 | 0.110 |
Why?
|
| Adenocarcinoma | 3 | 2016 | 7793 | 0.110 |
Why?
|
| Logistic Models | 2 | 2020 | 3450 | 0.110 |
Why?
|
| Pyruvic Acid | 1 | 2014 | 132 | 0.110 |
Why?
|
| Esophageal Neoplasms | 2 | 2016 | 3170 | 0.110 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 1748 | 0.110 |
Why?
|
| Medical Informatics | 1 | 2015 | 197 | 0.100 |
Why?
|
| Palliative Care | 1 | 2023 | 2037 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2015 | 273 | 0.100 |
Why?
|
| Diaphragm | 1 | 2013 | 181 | 0.100 |
Why?
|
| Shoulder | 1 | 2012 | 62 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2015 | 2801 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 695 | 0.100 |
Why?
|
| Lymphoma | 1 | 2019 | 1466 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2014 | 6891 | 0.090 |
Why?
|
| Disease Progression | 3 | 2019 | 6695 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 677 | 0.090 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 1431 | 0.090 |
Why?
|
| Software Validation | 1 | 2010 | 32 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2014 | 518 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 1303 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2017 | 1158 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2021 | 32991 | 0.090 |
Why?
|
| Dental Materials | 1 | 2009 | 7 | 0.090 |
Why?
|
| Dental Amalgam | 1 | 2009 | 8 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2421 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2023 | 16256 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 10066 | 0.080 |
Why?
|
| Deoxycytidine | 1 | 2014 | 1361 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 990 | 0.080 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 4868 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 1302 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 10356 | 0.080 |
Why?
|
| Computers | 1 | 2008 | 141 | 0.080 |
Why?
|
| X-Rays | 1 | 2008 | 146 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2010 | 602 | 0.080 |
Why?
|
| Genomics | 1 | 2019 | 2744 | 0.080 |
Why?
|
| Transistors, Electronic | 1 | 2007 | 7 | 0.080 |
Why?
|
| Technology, Radiologic | 1 | 2007 | 80 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2015 | 807 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6219 | 0.070 |
Why?
|
| Adolescent | 3 | 2023 | 31258 | 0.070 |
Why?
|
| Larynx | 1 | 2008 | 134 | 0.070 |
Why?
|
| Online Systems | 1 | 2006 | 27 | 0.070 |
Why?
|
| Body Size | 1 | 2006 | 70 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 2632 | 0.070 |
Why?
|
| Feedback | 1 | 2006 | 206 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 5541 | 0.060 |
Why?
|
| Radiation Protection | 1 | 2005 | 205 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 410 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2008 | 448 | 0.060 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 189 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2583 | 0.060 |
Why?
|
| Peritoneal Cavity | 1 | 2023 | 56 | 0.060 |
Why?
|
| Cobalt Radioisotopes | 1 | 2023 | 42 | 0.060 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 144 | 0.060 |
Why?
|
| Systems Integration | 1 | 2003 | 76 | 0.060 |
Why?
|
| Cobalt | 1 | 2023 | 56 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 5714 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 470 | 0.060 |
Why?
|
| Academies and Institutes | 1 | 2023 | 96 | 0.050 |
Why?
|
| Obesity | 1 | 2015 | 2893 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2015 | 7249 | 0.050 |
Why?
|
| Tanzania | 1 | 2022 | 69 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2023 | 660 | 0.050 |
Why?
|
| Checklist | 1 | 2022 | 124 | 0.050 |
Why?
|
| Income | 1 | 2022 | 225 | 0.050 |
Why?
|
| Zambia | 1 | 2020 | 26 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 104 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 332 | 0.050 |
Why?
|
| Radiobiology | 1 | 2020 | 56 | 0.050 |
Why?
|
| Tomography | 1 | 2020 | 55 | 0.050 |
Why?
|
| Technology | 1 | 2021 | 94 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 1949 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2021 | 233 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 4662 | 0.040 |
Why?
|
| Lasers | 1 | 2019 | 197 | 0.040 |
Why?
|
| Risk Factors | 2 | 2013 | 17607 | 0.040 |
Why?
|
| Mediastinum | 1 | 2019 | 269 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5099 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2018 | 313 | 0.040 |
Why?
|
| Masks | 1 | 2017 | 57 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 187 | 0.040 |
Why?
|
| Necrosis | 1 | 2017 | 585 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 523 | 0.030 |
Why?
|
| Osteocytes | 1 | 2015 | 27 | 0.030 |
Why?
|
| Survivors | 1 | 2021 | 1035 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 14594 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 78 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 863 | 0.030 |
Why?
|
| Fiducial Markers | 1 | 2015 | 96 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 237 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 1055 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 1392 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 73 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 1972 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 314 | 0.030 |
Why?
|
| Programming Languages | 1 | 2013 | 23 | 0.030 |
Why?
|
| Netherlands | 1 | 2013 | 83 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2014 | 211 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 625 | 0.030 |
Why?
|
| Colon, Sigmoid | 1 | 2013 | 42 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 575 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2014 | 210 | 0.030 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2016 | 565 | 0.030 |
Why?
|
| Adipocytes | 1 | 2015 | 304 | 0.030 |
Why?
|
| Radiation Monitoring | 1 | 2013 | 49 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 182 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 597 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 878 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 2906 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2018 | 1230 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 719 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1516 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 584 | 0.030 |
Why?
|
| Pneumonectomy | 2 | 2007 | 832 | 0.020 |
Why?
|
| Heterografts | 1 | 2014 | 734 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 483 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 625 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2010 | 66 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2014 | 654 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2017 | 855 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2014 | 638 | 0.020 |
Why?
|
| Consensus | 1 | 2014 | 998 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2013 | 693 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 1906 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4902 | 0.020 |
Why?
|
| Eye | 1 | 2010 | 300 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 1266 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2010 | 353 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4756 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 4321 | 0.020 |
Why?
|
| Mammography | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Heart Rate | 1 | 2010 | 736 | 0.020 |
Why?
|
| DNA Damage | 1 | 2015 | 1955 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5121 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 3024 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5158 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 316 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 695 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 2234 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 9186 | 0.020 |
Why?
|
| Pemetrexed | 1 | 2006 | 102 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 4318 | 0.020 |
Why?
|
| Glutamates | 1 | 2006 | 130 | 0.020 |
Why?
|
| Guanine | 1 | 2006 | 150 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 6307 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 13299 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 9293 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 4052 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 10009 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 2868 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3554 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12236 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 331 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 2233 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 629 | 0.010 |
Why?
|
| Cisplatin | 1 | 2006 | 2433 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 15195 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 3891 | 0.010 |
Why?
|
| United States | 1 | 2014 | 15562 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 14302 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 15874 | 0.000 |
Why?
|